Sales of Waters LC Systems Unaffected by Settlement, Ongoing Litigation with Agilent | GenomeWeb

Waters' settlement with rival Agilent last week of patent litigation in the United Kingdom and ongoing litigation elsewhere will have no effect on the firm's ability to sell its Alliance or Acquity liquid chromatography systems, a company official told BioCommerce Week late last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.